Id |
Subject |
Object |
Predicate |
Lexical cue |
T965 |
0-70 |
Sentence |
denotes |
We are grateful to the study participants who made this work possible. |
T966 |
71-229 |
Sentence |
denotes |
We would like to thank Bruce Horwitz, Ivan Zanoni, Matt Sampson, Michael Retchin, Peter Winter, Andrew Navia, Jamie Cohen, and Audrey Sporrij for discussions. |
T967 |
230-428 |
Sentence |
denotes |
Mengyang (Vicky) Li Horst, Timothy Tickle, Jonathan Bistline, Jean Chang, Eric Weitz, Eno-Abasi Augustine-Akpan, and Devon Bush for development and support of the Broad Institute Single Cell Portal. |
T968 |
429-897 |
Sentence |
denotes |
This work was supported in part by the Searle Scholars Program, the Beckman Young Investigator Program, the Pew-Stewart Scholars Program for Cancer Research, a Sloan Fellowship in Chemistry, the MIT Stem Cell Initiative through Fondation MIT, the 10.13039/100000002NIH (5U24AI118672 and BAA-NIAID-NIHAI201700104), and the 10.13039/100000865Bill and Melinda Gates Foundation to A.K.S., as well as NIH R56 AI139053 to J.L.F and P.L.L., and the Aeras Foundation to J.L.F. |
T969 |
898-958 |
Sentence |
denotes |
B.B. and S.K.N. are partially supported by NIH 5R01GM081871. |
T970 |
959-1405 |
Sentence |
denotes |
We acknowledge support from the 10.13039/100001021Damon Runyon Cancer Research Foundation (DRG-2274-16) and 10.13039/100001341Richard and Susan Smith Family Foundation to J.O.-M; from a National Science Foundation Graduate Research Fellowship (1122374) to S.K.N., S.J.A., and C.N.T.; from a Fannie and John Hertz Foundation Fellowship to C.N.T.; by T32GM007753 from the 10.13039/100000057National Institute of General Medical Sciences to C.G.K.Z. |
T971 |
1406-1672 |
Sentence |
denotes |
This work was further supported by the UMass Center for Clinical and Translational Science Project Pilot Program; and the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program (W81XWH-15-1-0317) to R.W.F. |
T972 |
1673-2378 |
Sentence |
denotes |
We also acknowledge support from 10.13039/100000002NIH grants AI078908, HL111113, HL117945, R37AI052353, R01AI136041, R01HL136209, and U19AI095219 to J.A.B.; by grants from the 10.13039/100000002NIH and National Heart, Lung, and Blood Institute (U19 HL129902) to H.P.K and L.S.K; from National Institute of Allergy and Infectious Diseases (UM1 AI126623) to H.P.K.; and to P.B. from the 10.13039/501100002915Fondation pour la Recherche Médicale (DEQ20180339158), and the 10.13039/501100001665Agence Nationale pour la Recherche (ANR-19-CE14-0027); and by the following grants to L.S.K: NIH/NIAID U19 AI051731, NIH/NHLBI R01 HL095791 NIH/NIAID R33-AI116184, NIH/NIAID U19 AI117945, and DHHS/NIH 1UM1AI126617. |
T973 |
2379-2484 |
Sentence |
denotes |
B.E.M. was supported by the Massachusetts Institute of Technology - GlaxoSmithKline (MIT-GSK) Gertrude B. |
T974 |
2485-2648 |
Sentence |
denotes |
Elion Postdoctoral Fellowship; T.M.L. by the NIH/NHLBI 1R01HL128241-01, K.M.B. by NIH/NIAID K23AI139352; and D.L. by NIH R01AI137057, DP2DA042422, and R01AI124378. |
T975 |
2649-2736 |
Sentence |
denotes |
This publication is part of the Human Cell Atlas (www.humancellatlas.org/publications). |